Advertisement
Research Article

CD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's Lymphoma

  • Karin U. Sorenmo equal contributor mail,

    equal contributor Contributed equally to this work with: Karin U. Sorenmo, Robert H. Vonderheide, Nicola J. Mason

    nmason@vet.upenn.edu (NJM); rhv@exchange.upenn.edu (RHV); karins@vet.upenn.edu (KUS)

    Affiliation: Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Erika Krick,

    Affiliation: Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Christina M. Coughlin,

    Affiliation: Department of Medicine, School of Medicine, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Beth Overley,

    Affiliation: Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Thomas P. Gregor,

    Affiliation: Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Robert H. Vonderheide equal contributor mail,

    equal contributor Contributed equally to this work with: Karin U. Sorenmo, Robert H. Vonderheide, Nicola J. Mason

    nmason@vet.upenn.edu (NJM); rhv@exchange.upenn.edu (RHV); karins@vet.upenn.edu (KUS)

    Affiliations: Department of Medicine, School of Medicine, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Nicola J. Mason equal contributor mail

    equal contributor Contributed equally to this work with: Karin U. Sorenmo, Robert H. Vonderheide, Nicola J. Mason

    nmason@vet.upenn.edu (NJM); rhv@exchange.upenn.edu (RHV); karins@vet.upenn.edu (KUS)

    Affiliations: Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Published: August 31, 2011
  • DOI: 10.1371/journal.pone.0024167

Reader Comments (1)

Post a new comment on this article

Media Coverage of This Article

Posted by PLoS_ONE_Group on 28 Oct 2011 at 17:39 GMT

The following article represents some of the media coverage that has occurred for this paper:

Publication: ECancer Medical Science
Title: “Cancer Journal: Latest cancer research Researchers demonstrate efficacy of non-Hodgkin's lymphoma vaccine | ecancermedicalscience”
http://www.ecancermedical...

Publication: The Daily Pennsylvanian
Title: “The Daily Pennsylvanian :: Penn research on canine lymphoma may work toward human cure”
http://thedp.com/index.ph...

If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.

Competing interests declared: PLoS ONE Staff